ALICIA HESS, APRN
Family Nurse Practitioner · BELLEAIR, FL
Individual Active NPI 1568955490
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 475 | 215,051 | $3,771,150 | $3,356,175 | $2,670,220 |
| 2023 | 374 | 88,959 | $2,867,658 | $2,533,823 | $2,012,369 |
| 2022 | 251 | 51,262 | $2,031,827 | $1,756,874 | $1,398,922 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 64,900 | $1 | $1 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 23,730 | $11 | $9 |
| J1306 | Injection, inclisiran, 1 mg | 18,460 | $12 | $9 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 13,860 | $18 | $14 |
| J0897 | Injection, denosumab, 1 mg | 12,240 | $25 | $20 |
| J0175 | Injection, donanemab-azbt, 2 mg | 8,400 | $4 | $3 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 8,400 | $18 | $14 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,100 | $29 | $23 |
| J0517 | Injection, benralizumab, 1 mg | 900 | $165 | $131 |
| 96372 | Injection of drug or substance under skin or into muscle | 563 | $12 | $9 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 204 | $102 | $81 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 163 | $50 | $39 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | ARNP9320458 | FL |
| Registered Nurse | 163W00000X | RN9320458 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Florida
- NPI 1003528258
- NPI 1760208219
- NPI 1487439394
- NPI 1811519994
- NPI 1407636582
- NPI 1629746243
- NPI 1215896980
- NPI 1508723081
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.